Stock Research: COSMOS Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

COSMOS Pharmaceutical

TSE:3349 JP3298400007
73
  • Value
    53
  • Growth
    95
  • Safety
    Safety
    23
  • Combined
    60
  • Sentiment
    71
  • 360° View
    360° View
    73
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

COSMOS Pharmaceutical Corporation operates drug stores, offering medical goods, cosmetics, and general food products. In the last fiscal year, the company had a market cap of $4962 millions, profits of $1481 millions, and revenue of $7022 millions.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 73 (better than 73% compared with alternatives), overall professional sentiment and financial characteristics for the stock COSMOS Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for COSMOS Pharmaceutical. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. The consolidated Safety Rank at 53 means that the company has a financing structure that is safer than 53% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 71, which means that professional investors are more optimistic about the stock than for 71% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 23, meaning that the share price of COSMOS Pharmaceutical is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 77% of alternative stocks in the same industry. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
23 31 23 17
Growth
95 69 51 75
Safety
Safety
53 55 69 67
Sentiment
71 91 49 45
360° View
360° View
73 79 42 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
45 57 29 29
Opinions Change
47 62 39 50
Pro Holdings
n/a 83 67 49
Market Pulse
72 71 75 65
Sentiment
71 91 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
23 31 23 17
Growth
95 69 51 75
Safety Safety
53 55 69 67
Combined
60 50 37 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
32 41 27 29
Price vs. Earnings (P/E)
38 48 43 38
Price vs. Book (P/B)
41 43 39 36
Dividend Yield
22 25 18 14
Value
23 31 23 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
75 70 70 65
Profit Growth
45 69 26 21
Capital Growth
84 48 44 55
Stock Returns
77 29 67 71
Growth
95 69 51 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
67 75 82 86
Refinancing
26 11 24 24
Liquidity
77 79 90 90
Safety Safety
53 55 69 67

Similar Stocks

Discover high‑ranked alternatives to COSMOS Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Tokuyama

TSE:4043
Country: Japan
Industry: Specialty Chemicals
Size: Medium
Full Stock Analysis

Daicel

TSE:4202
Country: Japan
Industry: Diversified Chemicals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.